Skip to main content
PETS logo

PetMed Express, Inc.

PETSNASDAQHealthcarePharmaceutical Retailers

$1.16Today:- (-)1Y −57.09%

As of Oct 26, 2026 close

Market cap
$25.15M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.15$4.10
Volume (live)
-
Avg. volume (3M)
138.81K

PetMed Express (PETS) Income Statement

PetMed Express reported revenue of $179.02M in fiscal 2026 (fiscal year ended Mar 31, 2026), down 21.1% from $226.97M a year earlier. PetMed Express posted a net loss of $57.29M, compared with a net loss of $6.27M a year earlier. Gross margin was 28.1% and operating margin -32.8%. In the most recent quarter, Q1 fiscal 2027 (ended Jun 30, 2026), revenue was $41.02M, down 19.9% from the same quarter a year earlier.

PetMed Express Income Statement Analysis

Values in millions USD

Scroll to see more
PetMed Express, Inc. income statement - Annual data in millions USD
BreakdownFY 2026FY 2025FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingMar 2026Jun 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Revenue & Gross Profit
Revenue179.02226.97226.97274.10247.57272.28303.58284.13283.42273.80249.18
Cost of Revenue128.81157.84157.84189.33171.07195.34219.27202.88188.11175.99169.86
Gross Profit50.2269.1469.1484.7776.5076.9484.3281.2595.3197.8179.31
Operating Expenses
Research & Development0.000.00-0.000.000.000.000.000.000.000.00
Selling, General & Administrative69.2262.4371.5785.2566.9049.9151.3648.0146.9243.5540.46
Operating Expenses108.8970.6770.6792.9370.4552.6553.7950.2749.1445.6741.83
Operating Income-58.67-1.53-1.53-8.166.0524.2930.5330.9846.1752.1437.48
Other Income/Expense
Interest Income0.510.000.190.510.45-1.13-0.901.751.860.660.14
Interest Expense0.000.00-0.000.00-1.13-0.900.000.000.000.00
Other Income/Expense1.310.940.941.890.94-0.110.422.922.951.650.44
Income
Income Before Tax-57.36-0.59-0.59-6.277.4524.1930.9533.8949.1253.7937.92
Income Tax Expense-0.075.685.681.192.315.477.038.0411.3816.5114.11
Net Income-57.29-6.27-6.27-7.465.1418.7223.9225.8537.7437.2823.82
Net Income - Continuous Operations-57.29-6.27--7.465.1421.1023.9225.8537.7437.2823.82
Net Income - Discontinued Operations-----------
EBITDA-19.006.71-1.250.619.6027.0332.9636.1551.3554.2638.85
EBIT-28.39--8.29-6.456.0524.2930.53----
Depreciation & Amortization9.397.047.046.063.552.742.432.262.232.131.37
Earnings Per Share
Basic EPS-3.00----1.001.001.002.002.001.00
Diluted EPS-3.00----1.001.001.002.002.001.00
Basic Shares Outstanding20.9220.6020.6020.4020.2820.1820.0620.0420.4620.3520.23
Diluted Shares Outstanding20.9220.6020.6020.4020.3420.3620.1220.0620.4920.4320.38

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About PetMed Express Financial Statements

What was PetMed Express's revenue in fiscal 2026?

PetMed Express reported revenue of $179.02M in fiscal 2026 (fiscal year ended Mar 31, 2026). That was down 21.1% from $226.97M a year earlier.

Is PetMed Express profitable?

No. PetMed Express reported a net loss of $57.29M in fiscal 2026. In fiscal 2025 it lost $6.27M.

What is PetMed Express's operating margin?

PetMed Express's operating income was −$58.67M on revenue of $179.02M in fiscal 2026, an operating margin of -32.8%, compared with -0.7% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition